Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Stock Price

DMAAStock
$10.75
Market Cap$260.98M
P/E43.77x
PEG Ratio
Div yield
Beta-0.01

DMAA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-8.76%
Price vs S&P 500 (4W)-0.60%
VGM Score58.99
P/E Ratio (Annual)43.77x

Industry Peers — Blank Checks / SPACs(917)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
DMAADrugs Made In America Acquisition Corp. Ordinary Shares
CB$10.75
DMIIDrugs Made In America Acquisition II Corp. Ordinary SharesC$10.14
EVACEQV Ventures Acquisition Corp. IIB$10.30
CXIIChurchill Capital Corp XII Class A Ordinary SharesA$10.83
BCSSBain Capital GSS Investment Corp.C$10.28
CEPFCantor Equity Partners IV, Inc. Class A Ordinary SharesC$10.36
AEXAAmerican Exceptionalism Acquisition Corp. AC$11.50
DBCAD. Boral Acquisition I Corp. Class A Ordinary SharesC$10.00
GHXIGores Holdings XI, Inc. Class A Ordinary SharesC$9.97
GCGRGeneral Catalyst Global Resilience Merger Corp. Class A Ordinary SharesC$10.18
NWAXNew America Acquisition I Corp.C$10.19

About Drugs Made In America Acquisition Corp. Ordinary Shares

Drugs Made In America Acquisition Corp is a special purpose acquisition company formed to identify and acquire pharmaceutical manufacturing companies operating in the United States. The company has not yet completed a business combination.